BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 9615303)

  • 1. The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma.
    Saraçlar Y; Sekerel BE; Kalayci O; Adalioğlu G; Tuncer A
    J Investig Allergol Clin Immunol; 1998; 8(2):98-104. PubMed ID: 9615303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
    Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.
    Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C
    Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
    Cevit O; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    J Investig Allergol Clin Immunol; 2007; 17(5):286-91. PubMed ID: 17982919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.
    Tari MG; Mancino M; Monti G
    Allergol Immunopathol (Madr); 1990; 18(5):277-84. PubMed ID: 2097894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [House dust mite allergy].
    Urbanek R; Behrle M; Kuhn W
    Padiatr Padol; 1991; 26(1):25-30. PubMed ID: 2057207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frequency of sensitization to D. pteronyssinus or D. farinae in children with perennial bronchial asthma].
    Zimmermann T; Mayer J
    Monatsschr Kinderheilkd; 1985 Apr; 133(4):214-8. PubMed ID: 4000137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity asthmatic children sensitized to house dust mites following sublingual immunotherapy.
    Silvestri M; Spallarossa D; Battistini E; Sabatini F; Pecora S; Parmiani S; Rossi GA
    J Investig Allergol Clin Immunol; 2002; 12(1):52-9. PubMed ID: 12109533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral response to subcutaneous, oral, and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus.
    Piazza I; Bizzaro N
    Ann Allergy; 1993 Nov; 71(5):461-9. PubMed ID: 7755664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies of the effectiveness of specific immunotherapy in house dust mite allergy].
    Ebner H; Neuchrist C; Havelec L; Kraft D
    Wien Klin Wochenschr; 1989 Aug; 101(15):504-11. PubMed ID: 2672610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.
    Wang DH; Chen L; Cheng L; Li KN; Yuan H; Lu JH; Li H
    Laryngoscope; 2013 Jun; 123(6):1334-40. PubMed ID: 23616386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
    Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
    Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of immunotherapy on histamine release: a study in allergy to dermatophagoides and house dust.
    Trento H; Oehling A; Ona J
    Allergol Immunopathol (Madr); 1982; 10(4):295-300. PubMed ID: 6184978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy in allergic rhinitis.
    Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
    Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial.
    Varney VA; Tabbah K; Mavroleon G; Frew AJ
    Clin Exp Allergy; 2003 Aug; 33(8):1076-82. PubMed ID: 12911781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study.
    Mungan D; Misirligil Z; Gürbüz L
    Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
    Du X; Shu C; Xu G; Ma M; Song H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.